Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
Incyte Corporation
BeOne Medicines
Pfizer
Chordia Therapeutics, Inc.
GluBio Therapeutics Inc.
Beijing InnoCare Pharma Tech Co., Ltd.
Beijing Biotech
TScan Therapeutics, Inc.
Bristol-Myers Squibb
Seagen Inc.
Blueprint Medicines Corporation
Incyte Corporation
Incyte Corporation
Taiho Oncology, Inc.
Merck Sharp & Dohme LLC
Enliven Therapeutics
Blueprint Medicines Corporation
Prelude Therapeutics
Italfarmaco
Remedy Plan, Inc.
Sumitomo Pharma America, Inc.
Incyte Corporation
AstraZeneca
Incyte Corporation
Crossbow Therapeutics, Inc.
Swedish Orphan Biovitrum
Takeda
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Disc Medicine, Inc
Novartis
Disc Medicine, Inc
Chengdu Zenitar Biomedical Technology Co., Ltd
Ossium Health, Inc.
Orca Biosystems, Inc.
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Cullinan Therapeutics Inc.
MacroGenics
Terns, Inc.
iOMEDICO AG
medac GmbH
Servier
Celgene
Ascentage Pharma Group Inc.
Massive Bio, Inc.
Rigel Pharmaceuticals
Ellipses Pharma
BlossomHill Therapeutics